Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension

被引：20
|
作者：
Perez-Villa, Felix [1 ]
Farrero, Marta [1 ]
Sionis, Alessandro [1 ]
Castel, Angeles [1 ]
Roig, Eulalia [1 ]
机构：
[1] Hosp Clin Barcelona, Thorax Inst, Heart Failure & Heart Transplantat Program, Barcelona, Spain
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2010年 / 29卷 / 07期
关键词：
D O I：
10.1016/j.healun.2010.02.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：817 / 818
页数：2
相关论文
共 50 条
  • [41] Heterotopic heart transplantation for severe pulmonary hypertension
    Wang, SS
    Chu, SH
    Ko, WJ
    Chen, YS
    Chou, NK
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3408 - 3409
  • [42] Bosentan Decreases Pulmonary Vascular Resistance and Improves Exercise Capacity in Acute Hypoxia
    Faoro, Vitalie
    Boldingh, Saskia
    Moreels, Mickael
    Martinez, Sarah
    Lamotte, Michel
    Unger, Philippe
    Brimioulle, Serge
    Huez, Sandrine
    Naeije, Robert
    CHEST, 2009, 135 (05) : 1215 - 1222
  • [43] Anti-inflammatory Effects of Bosentan Therapy in Patients With Severe Pulmonary Arterial Hypertension
    Karavolias, George
    Adamopoulos, Stamatis
    Karabela, Georgia
    Gouziouta, Aggeliki
    Domproglou, George
    Georgiadou, Panagiota
    Koutrouli, Eleana
    Chaidaroglou, Antigoni
    Degiannis, Dimitrios
    Voudris, Vassilis
    CIRCULATION, 2008, 118 (18) : S878 - S878
  • [44] Initial experience with bosentan for the management of pulmonary hypertension after heart transplantation
    Santiago-Vacas, Evelyn
    Farrero, Marta
    Ivey-Miranda, Juan B.
    Angeles Castel, Maria
    Garcia-Alvarez, Ana
    Rios, Jose
    Perez-Villa, Felix
    CLINICAL TRANSPLANTATION, 2018, 32 (09)
  • [45] First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension
    Lunze, K.
    Gilbert, N.
    Mebus, S.
    Miera, O.
    Fehske, W.
    Uhlemann, F.
    Muehler, E. G.
    Ewert, P.
    Lange, P. E.
    Berger, F.
    Schulze-Neick, I.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 32 - 38
  • [46] Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation
    Al-Kindi, Sadeer G.
    Farhoud, Mahmoud
    Zacharias, Michael
    Ginwalla, Mahazarin B.
    Elamm, Chantal A.
    Benatti, Rodolfo D.
    Oliveira, Guilherme H.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (03) : 209 - 215
  • [47] Severe pulmonary hypertension in patients eligible for heart transplantation. Is irreversible pulmonary hypertension still a contraindication?
    Frutos Seminario, F.
    Gonzalez-Costello, J.
    Diez-Lopez, C.
    Manito, N.
    Roca, J.
    Sanchez-Salado, J. C.
    Sbraga, F.
    Lopez-Cardozo, U.
    Garcia-Romero, E.
    Ariza-Sole, A.
    Lorente, V.
    Miralles, A.
    Blasco, A.
    Tatjer, I.
    Cequier, A.
    EUROPEAN HEART JOURNAL, 2018, 39 : 583 - 583
  • [48] Bosentan therapy in patients with pulmonary hypertension secondary to congenital heart disease (Eisenmenger physiology)
    D'Alto, M
    Sarubbi, B
    Vizza, CD
    Romeo, E
    Santoro, G
    Argiento, P
    Russo, MG
    Calabrò, R
    CHEST, 2005, 128 (04) : 366S - 366S
  • [49] THE ROLE OF SILDENAFIL IN PULMONARY HYPERTENSION FROM LEFT HEART DISEASE AND ELEVATED PULMONARY VASCULAR RESISTANCE: A SYSTEMATIC REVIEW AND METAANALYSIS
    Feghali, Elio Junior
    Yammine, Youssef
    CHEST, 2024, 166 (04) : 6519A - 6519A
  • [50] Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension
    Renard, Didier
    Bouillon, Thomas
    Zhou, Ping
    Flesch, Gerard
    Quinn, Debbie
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (01) : 75 - 85
12345